In fiscal year 2019, diagnostic drugs made up the largest portion of Fuji Pharma's sales with net sales amounting to around 10.83 billion Japanese yen. The Japanese pharmaceutical company focuses on medical care for women, in vitro diagnostics, acute medical care products, and curative medicine.
Net sales of Fuji Pharma Co. Ltd. in fiscal year 2019, by therapeutic category (in billion Japanese yen)
Basic Account
Get to know the platform
You only have access to basic statistics.
This statistic is not included in your account.
Single Account
The ideal entry-level account for individual users
- Instant access to 1m statistics
- Download in XLS, PDF & PNG format
- Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access
Corporate solution including all features.
* Prices do not include sales tax.
Further Content: You might find this interesting as well
Statistics
- Fuji Pharma's total assets FY 2013-2019
- Fuji Pharma's sales composition FY 2018, by therapeutic category
- Fuji Pharma's net sales FY 2013-2019
- Fuji Pharma's R&D costs FY 2013-2019
- Rebates/discounts by select companies as share of US pharma sales 2009-2013
- Top pharmaceutical companies in Colombia 2016, by sales
- Share of U.S imports of medical-pharma supplies, goods and products by country 2019
- Implementation of pharma track & trace in Russia 2019, by stage
- Top 50 pharmaceutical companies by prescription sales and R&D spending 2012
- Prescription drug advertising in the U.S. 2010-2014
- Number of companies in the pharmaceutical industry in France 1970-2018
- JW Pharmaceutical's operating profit 2014-2019
- Top rare disease therapeutic companies enterprise value worldwide 2000-2017
- Enterprise value of top companies in non-oncology rare disease therapeutics 2017
- JW Pharmaceutical's R&D spending South Korea 2014-2019
- JW Pharmaceutical's R&D spending ratio South Korea 2014-2019
- Argentina: genitourinary system & sexual hormones market revenue 2017-2019
- Astellas Pharma's female employee rate FY 2014-2017
- Astellas Pharma's female manager rate FY 2014-2017
Fuji Pharma. (November 26, 2020). Net sales of Fuji Pharma Co. Ltd. in fiscal year 2019, by therapeutic category (in billion Japanese yen) [Graph]. In Statista. Retrieved February 25, 2021, from https://www.statista.com/statistics/862893/fuji-pharma-net-sales-by-therapeutic-category/
Fuji Pharma. "Net sales of Fuji Pharma Co. Ltd. in fiscal year 2019, by therapeutic category (in billion Japanese yen)." Chart. November 26, 2020. Statista. Accessed February 25, 2021. https://www.statista.com/statistics/862893/fuji-pharma-net-sales-by-therapeutic-category/
Fuji Pharma. (2020). Net sales of Fuji Pharma Co. Ltd. in fiscal year 2019, by therapeutic category (in billion Japanese yen). Statista. Statista Inc.. Accessed: February 25, 2021. https://www.statista.com/statistics/862893/fuji-pharma-net-sales-by-therapeutic-category/
Fuji Pharma. "Net Sales of Fuji Pharma Co. Ltd. in Fiscal Year 2019, by Therapeutic Category (in Billion Japanese Yen)." Statista, Statista Inc., 26 Nov 2020, https://www.statista.com/statistics/862893/fuji-pharma-net-sales-by-therapeutic-category/
Fuji Pharma, Net sales of Fuji Pharma Co. Ltd. in fiscal year 2019, by therapeutic category (in billion Japanese yen) Statista, https://www.statista.com/statistics/862893/fuji-pharma-net-sales-by-therapeutic-category/ (last visited February 25, 2021)